MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy Cessation
88 percent of 64 patients remained without disease progression after median of 22.6 months after stopping immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.